World's 1st trial of drug developed from iPS cells to begin
Junya Toguchida, professor at Kyoto University, speaks at a press conference in Kyoto on Aug. 1, 2017, announcing that his team will begin the world's first clinical trial of a drug developed from induced pluripotent stem cells to treat fibrodysplasia ossificans progressiva, a rare bone disease. (Kyodo)
==Kyodo
- Product Code
- ILEA000113489
- Registered date
- 2017/8/01 12:42:49
- Credit
- Kyodo / Kyodo News Images
- Media source
- 2017 Kyodo News
- Media size
- 1545 × 1854 pixel
- Deployment size
- 358.78(KB)*
*File size when opened in Photoshop, etc.